» Articles » PMID: 40002547

Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review

Overview
Journal Brain Sci
Publisher MDPI
Date 2025 Feb 26
PMID 40002547
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive decline, primarily due to dysfunction of acetylcholine caused by acetylcholinesterase and butyrylcholinesterase. While synthetic cholinesterase inhibitors like donepezil, rivastigmine, and galantamine are commonly used, they have notable side effects, prompting interest in natural alternatives. Medicinal plants, rich in bioactive compounds like flavonoids and alkaloids, have shown potential as cholinesterase inhibitors with additional antioxidants and anti-inflammatory benefits. This study aimed to evaluate the cholinesterase-inhibiting effects of various plant species and their compounds to identify new therapeutic candidates and reduce side effects.

Method: A PRISMA-compliant review was conducted, screening studies from multiple databases, with a final inclusion of 64 in vivo studies.

Results: These studies highlighted plant extracts such as , , , and , which improved memory, reduced oxidative stress, and provided neuroprotection. Some extracts also reduced amyloid plaques, enhanced neuronal integrity, and restored cholinesterase activity, indicating their potential as therapeutic agents for AD and other neurodegenerative diseases.

Conclusions: The findings underscore the promise of plant-based compounds in treating cognitive decline and cholinergic dysfunction in AD, advocating for further research into their therapeutic potential.

References
1.
Bonesi M, Loizzo M, Conforti F, Passalacqua N, Saab A, Menichini F . Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity. J Pharm Pharmacol. 2013; 65(12):1726-35. DOI: 10.1111/jphp.12172. View

2.
Nazir N, Nisar M, Zahoor M, Uddin F, Ullah S, Ullah R . Phytochemical Analysis, In Vitro Anticholinesterase, Antioxidant Activity and In Vivo Nootropic Effect of () D. Don. in Scopolamine-Induced Memory Impairment in Mice. Brain Sci. 2021; 11(2). PMC: 7922987. DOI: 10.3390/brainsci11020259. View

3.
Page M, Moher D, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021; 372:n160. PMC: 8005925. DOI: 10.1136/bmj.n160. View

4.
Ahmed F, Murad Ghalib R, Sasikala P, Mueen Ahmed K . Cholinesterase inhibitors from botanicals. Pharmacogn Rev. 2013; 7(14):121-30. PMC: 3841990. DOI: 10.4103/0973-7847.120511. View

5.
Chen H, He X, Yuan R, Wei B, Chen Z, Dong J . Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia. 2016; 110:142-9. DOI: 10.1016/j.fitote.2016.03.011. View